HLS Therapeutics Inc (TSE:HLS) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
HLS Therapeutics Inc. is set to release its Q3 fiscal 2024 financial results on November 7, 2024, with a conference call to follow discussing the results. The company, which specializes in pharmaceutical products for psychiatric disorders and cardiovascular disease, continues to focus on North American markets.
For further insights into TSE:HLS stock, check out TipRanks’ Stock Analysis page.